AZD-5153
N/A
Report date: 2026/04/08 20:02:35
NME
Base Information
Drug NameAZD-5153
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[6]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAstrazeneca Plc
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesAstrazeneca PlcSierra Oncology Inc
Active IndicationsN/A
Inactive Indications +[6]
Other Information
ATC CodeN/A
Related LinksN/A